An ultra‐long‐acting recombinant insulin for the treatment of diabetes mellitus in cats

An ultra‐long‐acting recombinant insulin for the treatment of diabetes mellitus in cats

Abstract Background Treatment of diabetes mellitus (DM) in cats typically requires insulin injections q12h‐q24h, posing a major compliance barrier for caregivers. Novel treatments enabling decreased injection frequency while maintaining safety are highly desirable. Insulin fused with feline immunogl...

Full description

Bibliographic Details
Main Authors: Chen Gilor, Sean E. Hulsebosch, Jully Pires, Michael J. Bannasch, Thomas Lancaster, Andrea Delpero, Ramya Ragupathy, Sylaja Murikipudi, Todd Zion
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Journal of Veterinary Internal Medicine
Subjects:
adherence
compliance
continuous glucose monitoring
FcRn
IgG
Online Access:https://doi.org/10.1111/jvim.16150

Internet

https://doi.org/10.1111/jvim.16150

Similar Items